loadpatents
Patent applications and USPTO patent grants for Holzer; Philipp.The latest application filed is for "ai-based image analysis for the detection of normal images".
Patent | Date |
---|---|
Reduced interaction CT scanning Grant 11,284,850 - Singh , et al. March 29, 2 | 2022-03-29 |
Detection and quantification for traumatic bleeding using dual energy computed tomography Grant 11,210,779 - Xu , et al. December 28, 2 | 2021-12-28 |
Sensor-based patient treatment support Grant 11,207,035 - Eibenberger , et al. December 28, 2 | 2021-12-28 |
Ai-based Image Analysis For The Detection Of Normal Images App 20210383174 - Holzer; Philipp ;   et al. | 2021-12-09 |
Reduced Interaction Ct Scanning App 20210282730 - Singh; Vivek ;   et al. | 2021-09-16 |
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carbo- xamide Derivatives App 20210251996 - Arista; Luca ;   et al. | 2021-08-19 |
N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide Derivatives App 20210002285 - Arista; Luca ;   et al. | 2021-01-07 |
Sensor-based Patient Treatment Support App 20200323496 - Eibenberger; Eva ;   et al. | 2020-10-15 |
Detection And Quantification For Traumatic Bleeding Using Dual Energy Computed Tomography App 20200082525 - Xu; Zhoubing ;   et al. | 2020-03-12 |
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction Grant 9,556,180 - Furet , et al. January 31, 2 | 2017-01-31 |
Substituted purinone compounds Grant 9,403,827 - Furet , et al. August 2, 2 | 2016-08-02 |
Pyrrolopyrrolidinone compounds Grant 9,365,576 - Cotesta , et al. June 14, 2 | 2016-06-14 |
Pyrazolo[3,4-d]pyrimidinone Compounds As Inhibitors Of The P53/mdm2 Interaction App 20150353563 - FURET; Pascal ;   et al. | 2015-12-10 |
Substituted Purinone Compounds App 20150353551 - FURET; Pascal ;   et al. | 2015-12-10 |
Substituted isoquinolinones and quinazolinones Grant 9,051,279 - Berghausen , et al. June 9, 2 | 2015-06-09 |
Pyrazolopyrrolidine compounds Grant 8,969,341 - Furet , et al. March 3, 2 | 2015-03-03 |
Oxazine Derivatives And Their Use In The Treatment Of Neurological Disorders App 20150018338 - BADIGER; Sangamesh ;   et al. | 2015-01-15 |
Pyrazolopyrrolidine Compounds App 20140350010 - Furet; Pascal ;   et al. | 2014-11-27 |
Imidazopyrrolidinone Compounds App 20140343084 - FURET; Pascal ;   et al. | 2014-11-20 |
Method And Light Pulse Source For Generating Soliton Light Pulses App 20140334763 - Holzer; Philipp ;   et al. | 2014-11-13 |
Cyclohexyl isoquinolinone compounds Grant 8,859,586 - Furet , et al. October 14, 2 | 2014-10-14 |
Hydroxy substituted isoquinolinone derivatives Grant 8,859,535 - Buschmann , et al. October 14, 2 | 2014-10-14 |
Cyclohexyl Isoquinolinone Compounds App 20140275158 - Furet; Pascal ;   et al. | 2014-09-18 |
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases Grant 8,815,926 - Furet , et al. August 26, 2 | 2014-08-26 |
Hdyroxy Substituted Isoquinolinone Derivatives App 20140135306 - Buschmann; Nicole ;   et al. | 2014-05-15 |
Oxazine Derivatives And Their Use In The Treatment Of Neurological Disorders App 20140113894 - Holzer; Philipp ;   et al. | 2014-04-24 |
Oxazine Derivatives And Their Use In The Treatment Of Neurological Disorders App 20140088084 - Holzer; Philipp ;   et al. | 2014-03-27 |
Imidazopyrrolidinone Compounds App 20140011798 - FURET; Pascal ;   et al. | 2014-01-09 |
Pyrrolopyrrolidinone Compounds App 20130317024 - Cotesta; Simona ;   et al. | 2013-11-28 |
Substituted Isoquinolinones And Quinazolinones App 20130281473 - BERGHAUSEN; Joerg ;   et al. | 2013-10-24 |
Substituted isoquinolinones and quinazolinones Grant 8,440,693 - Berghausen , et al. May 14, 2 | 2013-05-14 |
Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors Grant 8,420,657 - Gaul , et al. April 16, 2 | 2013-04-16 |
Oxazine Derivatives And Their Use In The Treatment Of Neurological Disorders App 20120302558 - Badiger; Sangamesh ;   et al. | 2012-11-29 |
Oxazine Derivatives and their Use in the Treatment of Neurological Disorders App 20120238560 - HOLZER; Philipp ;   et al. | 2012-09-20 |
Oxazine Derivatives and their Use in the Treatment of Neurological Disorders App 20120172359 - BADIGER; Sangamesh ;   et al. | 2012-07-05 |
Oxazine derivatives and their use in the treatment of neurological disorders Grant 8,207,164 - Holzer , et al. June 26, 2 | 2012-06-26 |
Quinoxaline derivatives as tyrosine kinase activity inhibitors Grant 8,193,189 - Gerspacher , et al. June 5, 2 | 2012-06-05 |
Oxazine Derivatives And Their Use In The Treatment Of Neurological Disorders App 20110021520 - BADIGER; Sangamesh ;   et al. | 2011-01-27 |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors Grant 7,795,273 - Imbach , et al. September 14, 2 | 2010-09-14 |
Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors App 20100168062 - Gerspacher; Marc ;   et al. | 2010-07-01 |
3-Amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases App 20100093821 - Holzer; Philipp ;   et al. | 2010-04-15 |
Pyrimidine Derivatives App 20100010025 - Duthaler; Rudolf ;   et al. | 2010-01-14 |
Heterocyclic Compounds App 20090203688 - GAUL; Christoph ;   et al. | 2009-08-13 |
Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acids as Ephb and Vegfr2 Kinase Inhibitors App 20080300245 - Imbach; Patricia ;   et al. | 2008-12-04 |
3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors App 20080275054 - Holzer; Philipp ;   et al. | 2008-11-06 |
1,4 Substituted Pyrazolopyrimidines as Kinase Inhibitors App 20080096868 - Schmiedeberg; Niko ;   et al. | 2008-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.